Milestone Pharmaceuticals Inc. Accrued Income Taxes, Current
Milestone Pharmaceuticals Inc. (MIST) had Accrued Income Taxes, Current of $78.00 thousand as of 2019-03-31, per its 10-Q filed 2019-06-19.
Discontinued › Balance Sheet › Accrued Liabilities, Current
us-gaap:AccruedIncomeTaxesCurrent · last filed 2020-10-23
- 2019-03-31: Accrued Income Taxes, Current $78.00K.
- 2018-12-31: Accrued Income Taxes, Current $56.00K.
| Period end | Accrued Income Taxes, Current |
|---|---|
| 2019-03-31 | $78.00K 10-Q · filed 2019-06-19 |
| 2018-12-31 | $56.00K 10-K/A · filed 2020-10-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Anixa Biosciences Inc (ANIX) | United States | $0.096B | |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B |